TotalMarketCap

Lexaria Bioscience

LEXXNasdaq CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$8.784 M

$4.17 +2.46%

Close of 6 Nov 2026

As of 6 Nov 2026, Lexaria Bioscience (LEXX) has a market capitalization of $8.78M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$705.9K

#3484 by revenue

Earnings

-$11.9M

Loss-making

Shares outstanding

24,787,446

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #422BullFrog AIBFRG$9.02M
  2. #423BioLineRxBLRX$8.80M
  3. #424Lexaria BioscienceLEXX$8.78M
  4. #425CalciMedicaCALC$8.71M
  5. #426Lantern PharmaLTRN$8.09M

What if Lexaria Bioscience were worth as much as…

Open the what-if tool →

Gold $28.2T

$13,404,461

Per share 3,214,499× higher

Bitcoin $1.53T

$725,292.06

Per share 173,931× higher

Apple $5.02T

$2,381,066

Per share 570,999× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Lexaria Bioscience are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.